A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 2 - 21 |
Updated: | 1/13/2019 |
Start Date: | September 30, 2018 |
End Date: | April 2020 |
Contact: | Tianna Aronson |
Email: | tianna.d.aronson@medtronic.com |
Phone: | (508) 261-6049 |
A Prospective, Multi-center, Single Arm Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy
The purpose of this study is to assess safety and performance with the use of the BiZact™
device in tonsillectomy procedures in children and adolescents.
device in tonsillectomy procedures in children and adolescents.
A prospective, multi-center, single arm, study of BiZact™ on children and adolescents
undergoing tonsillectomy.
Study Visits:
- Screening/Baseline
- Surgery, Day 0
- Post-Op Follow-up Day 1 - Day 7, Day 10, & Day 14 (Home assessments)
- Post-Op Follow-up Day 28 (Office Visit)
undergoing tonsillectomy.
Study Visits:
- Screening/Baseline
- Surgery, Day 0
- Post-Op Follow-up Day 1 - Day 7, Day 10, & Day 14 (Home assessments)
- Post-Op Follow-up Day 28 (Office Visit)
Inclusion Criteria:
- Children and adolescent subjects 2-21 years of age at the time of the procedure,
inclusive
- Scheduled to undergo tonsillectomy
- The Subject or (if the subject is a minor) Subject's Parent/Legally Authorized
Representative (LAR) is willing to participate and consents to participate, as
documented by signed informed consent form and/ or assent form (as applicable)
Exclusion Criteria:
- Subjects undergoing:
1. Tonsillectomy as a result of cancer
2. Unilateral tonsillectomy
- Subjects with:
1. Known bleeding disorders
2. Current peritonsillar abscess
3. Craniofacial disorders
4. Down's syndrome (Trisomy 21)
5. Cerebral palsy
6. Major heart disease (including but not limited to; right-sided heart failure,
left-sided heart failure, congestive heart failure, coronary artery disease,
arrhythmias, chronic heart failure, acute heart failure, etc.)
7. Current tobacco use
- Subjects unable to comply with the required study follow-up visits
- Female subjects pregnant at time of procedure.
- The subject has comorbidities which, in the opinion of the Investigator, will not be
appropriate for the study or the subject has an estimated life expectancy - The
subject is participating or has participated in any drug or device research study
within 30 days of enrollment.
We found this trial at
3
sites
Charlotte, North Carolina 28210
Principal Investigator: Eric Mair
Phone: 704-295-3393
Click here to add this to my saved trials
2051 Charlie Hall Boulevard
Charleston, South Carolina 29414
Charleston, South Carolina 29414
Principal Investigator: William Brand
Phone: 843-518-5642
Click here to add this to my saved trials
Click here to add this to my saved trials